Chembio to Hold Conference Call Today at 4:30 ET to Discuss Marketing Partner Agreements for Rapid HIV Tests.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Chembio Diagnostics, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CEMI CEMI Center for Experimental Music and Intermedia (University of North Texas, Denton, TX) CEMI Communications-Electronics Maintenance Instruction ) will host a conference call today, Tuesday October 10th at 4:30pm ET to discuss the recently announced financing and marketing partner agreements for Chembio's rapid HIV tests. Chembio invites all those interested in hearing management's discussion of the recent events to join the call by dialing (877) 407-0782. International participants may access the call by dialing 201-689-8567. A live web cast can be accessed by clicking on the following link http://www.vcall.com/IC/CEPage.asp?ID=109970. A replay of this web cast can also be accessed using the same link. ABOUT CHEMBIO Chembio Diagnostics, Inc., a developer and manufacturer of rapid diagnostic tests for infectious diseases infectious diseases: see communicable diseases. , is on the frontlines of the global battle against the AIDS pandemic. The Company has received marketing approval from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for its SURE CHECK(R) HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. 1/2 and HIV 1/2 STAT-PAK(TM) rapid tests. The Company also manufactures rapid tests for veterinary Tuberculosis and Chagas Disease Cha·gas disease or Cha·gas-Cruz disease n. See South American trypanosomiasis. , and has developed a patent-pending technology, the Dual Path Platform (DPP DPP - Dining Philosophers Problem (TM)), for its next generation HIV and other rapid tests. For additional information please visit www.chembio.com. FORWARD-LOOKING STATEMENTS Statements contained herein that are not historical facts may be forward-looking statements within the meaning of the Securities Act of 1933, as amended. Forward-looking statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements are estimates only, as the Company has not completed the preparation of its financial statements for those periods, nor has its auditor completed the audit of those results. Actual revenue may differ materially from those anticipated in this press release. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to Chembio's ability to obtain additional financing, to obtain regulatory approvals in a timely manner, and the demand for Chembio's products. Chembio undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in Chembio's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact Chembio's success are more fully disclosed in Chembio's most recent public filings with the U.S. Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion